See other companies on Welcome to the Jungle
Lokavant
Clinical trial intelligence platform
- 21-100 employees
- Healthcare
- B2B
- Analytics
- SaaS
- Science
- Theater District, New York, NY
Jump to section
Company mission
To Make Clinical Trials Smarter
Our take
Addressing the oft-reported bottleneck in clinical drug trial implementation, Lokava uses advanced analytics to improve the time, cost, and quality of the process.
From complex and shifting eligibility criteria for test subjects, vast data sources, and a lack of infrastructure available to connect trials to vendors, Lokova is taking data analytics into vital new areas.
Lokava will use funds from Edison Partners to expand its commercial teams and platform capabilities. Roivant Sciences, a tech and science company that develops new medicines, also took part in this funding round, indicating the potential of a partnership with Lokava.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Employee Assistance Program (EAP)
- Employee stock options
- Great NYC office located in the heart of Times Square
- Discounts on auto, home, and pet insurance
- Full medical, dental, and vision benefits, including mental health and telehealth
- Free membership to One Medical
- 401(k) retirement savings plan with company match
- Flexible paid time off policy
- Flexible remote work policy
- Commuter benefits
- Generous paid parental leave policy
- Health Advocate program
- Short and long-term disability insurance
- Basic and supplemental life and AD&D insurance
- Healthcare & dependent care Flexible Spending Accounts (FSA)
- Team-building events and outings
- Learning and professional development opportunities
- Employee referral program
Funding (2 rounds)
Oct 2023
$8m
EARLY VC
Dec 2022
$21m
GROWTH EQUITY VC
Total funding: $29m
Leadership
Rohit Nambisan
(CEO)Previously Head of Digital Product at Roivant Services, BD/Product Consultant at Nym and SVP, Product Strategy & Partner Integration at Treato.